Market Report: BHP and Rio are good buys 'alone or together'

BHP Billiton and Rio Tinto got a shot in the arm from Sanford Bernstein yesterday. The broker said that the two companies were compelling "alone or together," adding: "We believe the best strategy is to own both BHP Billiton and Rio Tinto to reduce risks of potential changes to their proposed merger... Beyond [the current] bid period, we see a benefit in owning either stock if the transaction concludes.

"Both companies are likely to benefit from their respective commodity exposures. While BHP Billiton will be gaining some immediate benefit from high oil prices, we see Rio Tinto's relatively high aluminium exposure (17 per cent of 2008 Ebitda) as a strength," the broker concluded.

The positive assessment was accompanied with an upgrade for each to outperform from market-perform. As a result, Rio Tinto rose by 252p to 5,694p, while BHP Billiton added 57p to 1,617p.

Bernstein also upgraded Xstrata, to market-perform from under-perform. The Anglo-Swiss miner gained 127p to 3,707p.

House-builders, on the other hand, were weak after analysts at Cazenove said the recent share price bounce in the sector was "unjustified" and did not reflect underlying market conditions. The downbeat assessment took Persimmon to 719p, down by 2.97 per cent or 22p. The company ended the day at second place on the FTSE 100 loser board. Bovis Homes lost 34p to 590p, while Bellway was weaker by 47p at 843p. Other house-builders, including Taylor Wimpey, which shed 4.25p to 181.75p, Redrow, which was down by 12.50p to 312.25p, and Barratt Developments, which lost 20.75p to 401.50p, were also off-colour.

Overall, the FTSE 100 was up 55.80 points to 5,947.10. The London benchmark was kept firm by bid talk around British Energy. A report in the French newspaper La Tribune suggested that EDF was about to make an offer for the British company, sending its shares up by 48.50p to 711p, to first place on the FTSE 100 leader board.

The speculation helped the benchmark to survive the effects of some disappointing US economic data. The Labour Department said that the US economy shed 80,000 non-farm jobs in March, the third consecutive month of contraction in the labour market. The decline was worse than many in the market expected and the sharpest in five years, reinforcing the view that a US recession was well under way.

The FTSE 250 was down, shedding 12.10 points to 10,165.10.

On the FTSE 100, pharmaceutical stocks showed some strength yesterday. GlaxoSmithKline was up 14p to 1,135p after the US Food and Drug Administration approved its Rotarix rotavirus infant vaccine.

Sector peer AstraZeneca was also up, gaining 60p to 2,110p after Morgan Stanley upgraded its target price for the stock to 2,200p from 2,150p. This was the second broker upgrade for the company this week. On Tuesday, Citigroup revised its rating for the stock to "buy" from "hold".

On the FTSE 250, Close Brothers climbed to third place on the leader board after analysts at Landsbanki initiated coverage on the stock with a "buy" recommendation. "After poor share price performance over five years, Close recently dashed hopes of a bid," said the Landsbanki analyst Ian Poulter. "However, with market forecasts for Close incorporating a pessimistic outlook, we believe the shares will show outperformance as the group utilises its surplus capital to better effect. It has room for accelerated growth and could still consider further capital returns," he added. By the end of the day, Close Brothers was up 33p at 674p.

FKI was weak yesterday as the market awaited a formal bid from Melrose, the engineering conglomerate which has been studying the firm's books. Rumours that a bid was due early next week failed to excite investors – the company has been a recurrent feature in market speculation over the past week. FKI closed down 0.25p at 71.25p.

Among smaller companies, SCI Entertainment gained 20.40 per cent or 10.25p to 60.50p on the back of bid rumours. The speculation suggested that the company, which owns the video games publisher Eidos, was about to be subject to a 100p per share offer. On market source suggested that the suitor may be a larger American peer.

The semiconductor maker Zetex soared by 88.51 per cent or 38.50p to 82p after US peer Diodes made a recommended 85.45p per share offer for the company. The offer represents a 96 per cent premium on Zetex's closing price on Thursday, valuing it at £89.1m.

On AIM, Hichens, Harrison & Co, London's oldest stockbroker, was up 6p at 275p after reaching agreement over a takeover offer. The £55m deal will see Hichens, founded in 1803, pass into the hands of India's Religare Capital Markets.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Sales Assistant / Buyer

£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: Customer Service Advisors are r...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree were established in 1986....

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

Day In a Page

Greece debt crisis: What happened to democracy when it’s a case of 'Vote Yes or else'?

'The economic collapse has happened. What is at risk now is democracy...'

If it doesn’t work in Europe, how is it supposed to work in India or the Middle East, asks Robert Fisk
The science of swearing: What lies behind the use of four-letter words?

The science of swearing

What lies behind the use of four-letter words?
The Real Stories of Migrant Britain: Clive fled from Zimbabwe - now it won't have him back

The Real Stories of Migrant Britain

Clive fled from Zimbabwe - now it won’t have him back
Africa on the menu: Three foodie friends want to popularise dishes from the continent

Africa on the menu

Three foodie friends want to popularise dishes from the hot new continent
Donna Karan is stepping down after 30 years - so who will fill the DKNY creator's boots?

Who will fill Donna Karan's boots?

The designer is stepping down as Chief Designer of DKNY after 30 years. Alexander Fury looks back at the career of 'America's Chanel'
10 best statement lightbulbs

10 best statement lightbulbs

Dare to bare with some out-of-the-ordinary illumination
Wimbledon 2015: Heather Watson - 'I had Serena's poster on my wall – now I'm playing her'

Heather Watson: 'I had Serena's poster on my wall – now I'm playing her'

Briton pumped up for dream meeting with world No 1
Wimbledon 2015: Nick Bollettieri - It's time for big John Isner to produce the goods to go with his thumping serve

Nick Bollettieri's Wimbledon Files

It's time for big John Isner to produce the goods to go with his thumping serve
Dustin Brown: Who is the tennis player who knocked Rafael Nadal out of Wimbeldon 2015?

Dustin Brown

Who is the German player that knocked Nadal out of Wimbeldon 2015?
Ashes 2015: Damien Martyn - 'England are fired up again, just like in 2005...'

Damien Martyn: 'England are fired up again, just like in 2005...'

Australian veteran of that Ashes series, believes the hosts' may become unstoppable if they win the first Test
Tour de France 2015: Twins Simon and Adam Yates have a mountain to climb during Tour of duty

Twins have a mountain to climb during Tour of duty

Yates brothers will target the steepest sections in bid to win a stage in France
John Palmer: 'Goldfinger' of British crime was murdered, say police

Murder of the Brink’s-MAT mastermind

'Goldfinger' of British crime's life ended in a blaze of bullets, say police
Forget little green men - aliens will look like humans, says Cambridge University evolution expert

Forget little green men

Leading evolutionary biologist says aliens will look like humans
The Real Stories of Migrant Britain: An Algerian scientist adjusts to life working in a kebab shop

The Real Stories of Migrant Britain

An Algerian scientist struggles to adjust to her new life working in a Scottish kebab shop
Bodyworlds museum: Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy

Dying dream of Doctor Death

Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy